News & Updates
Filter by Specialty:
HK’s first territory-wide long COVID study to inform follow-up care
Researchers at the Chinese University of Hong Kong (CUHK) have rolled out the city’s first territory-wide study of long COVID to inform multidisciplinary follow-up care for thousands of COVID-19 survivors. Participants are also invited to a second-phase 3-year prospective study of the impact of gut dysbiosis on long COVID symptoms and the potential role of gut microbiome modulation in treatment of long COVID.
HK’s first territory-wide long COVID study to inform follow-up care
01 Aug 2022
Which drugs raise risk of urinary tract infections?
Some medications may directly cause the occurrence of urinary tract infections (UTIs), and a recent study presented at the 37th Annual European Association of Urology Congress (EAU 2022) has identified six drugs that appear to contribute to “significant reporting levels” for infections.
Which drugs raise risk of urinary tract infections?
29 Jul 2022
Paternal IBD medication use before conception carries no excess risk of childhood infections
Fathers’ exposure to anti-inflammatory or immunosuppressive medications for inflammatory bowel disease (IBD) prior to conception does not appear to contribute to a significantly increased risk of childhood infections, a study has found.
Paternal IBD medication use before conception carries no excess risk of childhood infections
28 Jul 2022
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
For women with acute uncomplicated cystitis, treatment regimens that include third- and fourth-generation quinolones and pivmecillinam can be administered in shorter courses, which perform similarly to the currently recommended regimens in terms of achieving symptomatic cure, according to the results of a meta-analysis presented at the 37th Annual European Association of Urology (EAU) Congress.
